Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.

Antimicrobial agents and chemotherapy - 1 Oct 2005

von Eiff Christof, Friedrich Alexander W, Becker Karsten, Peters Georg

Abstract excerpt

The antistaphylococcal activity of ceftobiprole was compared with those of cefuroxime, linezolid, and moxifloxacin by using the agar dilution method. Apart from three strains with small-colony variant phenotypes, all Staphylococcus aureus isolates tested were inhibited by < or =2 microg/ml of ceftobiprole. This compound exhibited an excellent antistaphylococcal activity, comparable to that of linezolid.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetamides
Share to Aza Compounds
Share to Cephalosporins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linezolid

Share to Moxifloxacin

Share to Oxazolidinones

Share to Quinolines

Share to Staphylococcus

Source

Open in PubMed Open full text

Identifiers

PMID: 16189125
DOI: 10.1128/AAC.49.10.4372-4374.2005
PMCID: PMC1251552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.PMID 16189125Read ↗

Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.Semantic proximity Read ↗

Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype.Semantic proximity Read ↗

In Vitro Activities of Ceftobiprole, Tigecycline, Daptomycin, and 19 Other Antimicrobials against Methicillin-Resistant Staphylococcus aureus Strains from a National Survey of Belgian HospitalsSemantic proximity Read ↗

Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.Semantic proximity Read ↗

In vitro activity of linezolid against staphylococci.Semantic proximity Read ↗

In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.Semantic proximity Read ↗

Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data.Semantic proximity Read ↗

Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.